Haemodynamic changes with paracetamol in critically-ill children

Samiran Ray1, Thomas Brick2, Sainath Raman1

  • 1Paediatric Intensive Care Unit, Great Ormond Street Hospital, London, WC1N 3JH, UK; Respiratory, Anaesthesia and Critical Care Section, UCL Institute of Child Health, London, WC1N 1EH, UK.

Insights

Paracetamol administration in critically-ill children causes a modest reduction in blood pressure. This effect is more pronounced in children with fever but not significantly related to body surface area to weight ratio.

Area of Science:

  • Pediatric critical care medicine
  • Pharmacology
  • Cardiovascular physiology

Background:

  • Paracetamol (acetaminophen) is commonly used for fever and pain management in children.
  • Previous studies suggest paracetamol may reduce blood pressure in febrile, critically-ill adults.
  • The impact of paracetamol on blood pressure in critically-ill children requires further investigation.

Purpose of the Study:

  • To investigate the effect of paracetamol on blood pressure in critically-ill children.
  • To determine if fever or body surface area to weight ratio influences this effect.
  • To explore the hemodynamic mechanisms underlying blood pressure changes.

Main Methods:

  • Prospective observational study over 12 months.
  • Inclusion of children aged 0-16 years admitted to pediatric intensive care.
  • Utilized pulse contour analysis for continuous blood pressure monitoring during paracetamol administration.

Main Results:

  • Mean arterial blood pressure decreased by 4.7% post-paracetamol administration.
  • The blood pressure nadir occurred 2 hours after dosing.
  • A trend towards a greater reduction was observed in febrile children (6.4%), though not statistically significant.
  • No clear relationship was found with body surface area to weight ratio.
  • Changes in heart rate or stroke volume poorly correlated with blood pressure changes, suggesting a role for systemic vascular resistance.

Conclusions:

  • Paracetamol administration leads to a significant, albeit modest, reduction in blood pressure in critically-ill children.
  • The observed hypotension is likely mediated by a decrease in systemic vascular resistance.
  • Further research is warranted to fully elucidate the hemodynamic effects and clinical implications.
Abstract

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...